In a stark warning issued ahead of World No Tobacco Day on May 31, the World Health Organization (WHO) has sounded a global alarm regarding the meteoric rise of nicotine pouches. These small, discreet sachets—designed to be placed between the gum and the lip—are the latest iteration of nicotine delivery systems, and health officials warn they are being aggressively marketed to a demographic most vulnerable to their effects: the youth.
As the industry pivots away from traditional combustible cigarettes, nicotine pouches have emerged as a multi-billion-dollar enterprise. With little to no regulatory oversight in most jurisdictions, the WHO is calling for immediate, evidence-based intervention to prevent a new generation from falling into the cycle of chemical dependency.
The Evolution of a Global Crisis: A Chronology of Growth
The surge in nicotine pouch usage has been both rapid and calculated. Unlike traditional smokeless tobacco products, these pouches are often tobacco-free, relying instead on synthetic nicotine, flavorings, and sweeteners.
- 2020–2022: The Incubation Phase: While nicotine pouches existed as a niche product, the industry began refining its marketing strategies, focusing on the “discreet” and “clean” nature of the product. Manufacturers positioned them as an ideal alternative for situations where smoking or vaping was prohibited.
- 2023: The Regulatory Vacuum: As sales began to climb, governments worldwide struggled to classify these products. Because they often contain no tobacco leaf, they frequently slipped through the gaps of existing tobacco control legislation, leaving them untaxed and largely unmonitored.
- 2024: Exponential Market Expansion: The industry saw a massive shift in scale. Retail sales eclipsed 23 billion units, marking a staggering 50% increase from the previous year. The market’s valuation began to skyrocket as global distribution networks expanded.
- 2025: A US$ 7 Billion Industry: By the end of 2025, the global market for nicotine pouches reached nearly US$ 7 billion. The industry’s focus shifted toward aggressive, multi-channel marketing, including social media influencer partnerships and youth-oriented packaging.
- 2026: The WHO Intervention: In preparation for World No Tobacco Day, the WHO published its first comprehensive report, “Exposing marketing tactics and strategies driving the growth of nicotine pouches.” This report serves as a formal mandate for member states to close regulatory loopholes and treat these products with the same rigor as traditional tobacco.
Supporting Data: By the Numbers
The raw data behind the WHO’s warnings paints a concerning picture of a product engineered for rapid adoption and long-term addiction.
- Explosive Volume: The leap to 23 billion units in annual sales indicates that these products are no longer a boutique item; they are a mass-market commodity.
- Nicotine Concentrations: The WHO has flagged products labeled with nicotine amounts as high as 150 mg. For context, this is a massive dosage compared to traditional cigarettes, significantly increasing the risk of acute toxicity and severe, rapid-onset addiction.
- The Tiered Trap: Manufacturers are now marketing products in tiers labeled “beginners,” “advanced,” and “experts.” This strategy mimics the gaming industry, gamifying the addiction process and encouraging users to “graduate” to higher concentrations of nicotine as their tolerance increases.
- Economic Footprint: The US$ 7 billion valuation is projected to grow unless aggressive, coordinated regulatory frameworks are implemented. This capital enables the industry to outspend public health campaigns, saturating digital spaces with advertisements designed to bypass the critical thinking of young adults.
Official Responses: The Health Imperative
The WHO’s response is led by experts who emphasize that the “clean” branding of these pouches is a deceptive marketing veneer.
Dr. Vinayak Prasad, Unit Head of the Tobacco Free Initiative for the WHO, minced no words regarding the current regulatory climate. “The use of nicotine pouches is spreading rapidly, while regulation struggles to keep pace,” Dr. Prasad stated. “Governments must act now with strong, evidence-based safeguards. We are witnessing the industry iterate on its products to maintain a user base that would otherwise have been lost to smoking cessation.”
Dr. Etienne Krug, Director of the Department of Health Determinants, Promotion and Prevention at the WHO, added that the threat to the younger generation is a direct assault on public health. “These products are engineered for addiction, and there is a strong need to protect our youth from industry manipulation,” Dr. Krug explained. “We are seeing products that mimic candy packaging, designed to lower the risk perception of children and adolescents.”
The Anatomy of Addiction: Why Youth are at Risk
The WHO’s concerns are rooted in the physiological impact of nicotine on the developing human brain. During adolescence and young adulthood, the brain is undergoing critical neurodevelopmental processes.
Nicotine is a potent neurotoxin that can disrupt these processes. Exposure during this window of development is linked to:
- Cognitive Impairment: Impacts on attention, focus, and learning abilities that can persist well into adulthood.
- Structural Changes: Changes to the neural pathways that govern impulse control and emotional regulation.
- Gateway Effect: Early nicotine exposure is a well-documented predictor of future substance use, increasing the likelihood that a user will transition to other tobacco or nicotine products, including combustible cigarettes.
Beyond the neurological impact, the physical health risks remain significant. Nicotine is a vasoconstrictor, meaning it increases blood pressure and heart rate, leading to long-term cardiovascular risks that are often ignored by users who believe the “tobacco-free” label implies a “harm-free” experience.
Regulatory Gaps and the Path Forward
The WHO report highlights that nicotine pouches often fall into a "regulatory purgatory"—they are not always classified as medicine, nor are they always classified as tobacco. This ambiguity has allowed companies to operate in a legal gray area.
To address this, the WHO has issued a call for comprehensive, global regulation:
- Standardized Licensing: Governments should treat nicotine pouches as nicotine-containing products under the same strict regulatory framework as tobacco, including age restrictions, bans on sales to minors, and strict tax structures.
- Advertising Bans: The WHO advocates for a total ban on the marketing tactics currently being used, particularly those that target youth through social media or candy-themed branding.
- Packaging Mandates: Plain packaging and clear, mandatory health warnings must be implemented to strip away the “lifestyle” allure that companies have attached to the product.
- Strength Limitations: There must be a cap on the concentration of nicotine allowed in these products to prevent the dangerous, tiered “beginner-to-expert” escalations.
Implications: A New Generation at the Crossroads
The global community stands at a crossroads. The rise of nicotine pouches is not merely a commercial trend; it is a public health challenge that tests the efficacy of international health governance. If left unchecked, the industry’s strategy of normalization will likely succeed in capturing a new, lifelong user base.
The WHO’s upcoming World No Tobacco Day 2026, themed “Together for health. Stand with science,” serves as a rallying cry. By prioritizing scientific evidence over industry-funded misinformation, governments have a narrow window to implement the necessary safeguards.
Ultimately, the goal is to dismantle the industry’s attempts to frame nicotine as a harmless habit. Through the harmonization of international laws and the rejection of deceptive marketing, the global health community hopes to protect the cognitive and physical development of the next generation, ensuring that the "industry manipulation" identified by the WHO does not become the new normal for today’s youth.
As the WHO report concludes, the time for passive observation has passed. Urgent, coordinated action is required to ensure that the 23 billion units sold in 2024 do not serve as the foundation for a preventable epidemic of 21st-century nicotine dependence.
About the Author
